Explore our database of over 4000 laboratory markers.
Search and Understand 4000+ Biomarkers
Optimal range: 1.3 - 50 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 50 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 10 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 50 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Optimal range: 1.3 - 50 ug/ml
The detection of pneumococcal IgG antibodies is helpful for the evaluation of response to pneumococcal vaccination and need for revaccination.
Reference range: Vaccinated, Not Vaccinated
Pneumonia is a severe respiratory infection that inflames the air sacs in one or both lungs, potentially filling them with fluid or pus. Symptoms include cough, fever, chills, and difficulty breathing. Pneumonia can be caused by bacteria, viruses, or fungi, with pneumococcal pneumonia, caused by Streptococcus pneumoniae, being particularly dangerous. The pneumococcal vaccination is crucial in preventing this infection. There are two main types of vaccines: pneumococcal conjugate vaccines (PCV15, PCV20) and the pneumococcal polysaccharide vaccine (PPSV23). These vaccines are recommended for children under five, adults over 65, and individuals aged 19-64 with specific risk factors. Vaccination not only protects individuals from serious illness but also reduces the spread of the infection within the community. Regular vaccination tracking and consultation with healthcare providers are essential to ensure timely and appropriate vaccination, thereby enhancing individual and public health.
